ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 6969

$1.16M Total Retail Price of All Prescriptions

Rank: 108 out of 6969

567 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,033 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SYNTHROID 790 732 1 94
LISINOPRIL 630 574 2 2
SIMVASTATIN 608 545 3 1
CRESTOR 601 523 4 39
ALLOPURINOL 565 516 5 35
METFORMIN HCL 550 515 6 7
TRILIPIX 446 411 10 7 175
NIASPAN 381 330 8 146
CARVEDILOL 293 280 9 25
ZETIA 279 254 10 98
ACTOS 246 232 11 61
HYDROCODONE-ACETAMINOPHEN 238 178 S3 12 3
ALENDRONATE SODIUM 221 218 13 14
FUROSEMIDE 220 181 14 10
AMLODIPINE BESYLATE 191 188 15 4
LEVOTHYROXINE SODIUM 173 166 16 5
VYTORIN 159 152 17 148
BENAZEPRIL HCL 154 140 18 18
ZOLPIDEM TARTRATE 151 137 19 16
PANTOPRAZOLE SODIUM 147 144 20 31
POTASSIUM CHLORIDE 138 126 21 30
OMEPRAZOLE 134 102 22 6
LOSARTAN POTASSIUM 128 116 23 12
WARFARIN SODIUM 124 118 24 20
TRAMADOL HCL 117 115 25 27
FLUOXETINE HCL 106 84 26 43
DICLOFENAC SODIUM 105 97 27 78
GABAPENTIN 104 79 28 17
PIOGLITAZONE HCL 100 86 R 29 174
ATENOLOL 97 80 30 9
NAMENDA 96 93 31 51
DIOVAN 95 95 32 26
LOVASTATIN 92 82 33 15
JANUVIA 87 83 34 41
EXELON 80 80 35 157
DONEPEZIL HCL 79 79 36 32
DIOVAN HCT 77 77 37 57
ATORVASTATIN CALCIUM 77 73 37 11
LEVOFLOXACIN 76 57 39 109
DIGOXIN 75 75 40 71
LANTUS SOLOSTAR 73 53 41 154
TRICOR 73 65 41 143
DOXAZOSIN MESYLATE 73 69 41 74
METOPROLOL TARTRATE 72 72 44 13
TAMSULOSIN HCL 72 65 44 23
METOPROLOL SUCCINATE 69 66 46 22
LOSARTAN-HYDROCHLOROTHIAZIDE 68 50 47 53
LANSOPRAZOLE 66 63 48 171
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 43 48 114
ALPRAZOLAM 65 54 50 172
CIPROFLOXACIN HCL 59 54 51 64
MELOXICAM 58 53 52 36
EVISTA 56 56 53 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 55 53 28
CLOPIDOGREL 53 51 55 48
DILTIAZEM 24HR ER 53 53 55 183
CEFDINIR 53 37 55 338
MIRTAZAPINE 53 53 55 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.